Pfizer wins retrial in bellwether hormone case; Sun gets first-to-file OK for generic Namenda;

 @FiercePharma: J&J compliance to tag along on sales calls. Article | Follow @FiercePharma

> $1B in cash grants available soon for small biotech. Feature

> A Pfizer unit won a retrial of a Pennsylvania lawsuit over its menopause drugs that ended in a first jury's award of $1.5 million in damages, the company said. Report

> Sun Pharmaceutical Industries got the FDA nod for its version of Forest Laboratories' Alzheimer's drug Namenda in 5 mg and 10 mg tablets. Sun release

> A new study designed to answer questions about the safety of Merck's shingles vaccine suggests it doesn't significantly increase the risk of serious side effects. Report

> A Pennsylvania woman sued GlaxoSmithKline, claiming harmful levels of zinc in the company's Super Poligrip denture cream led to a nerve disorder that forced her to resign her clerical job and left her unable to drive or to walk without a walker or cane. Report

> Beximco Pharmaceuticals said it is in talks with major Western pharmaceutical companies about manufacturing their products under contract at its facilities in Bangladesh. Report (sub. req.)

> Dutch biotech Crucell said on Thursday it had won a $110 million order from UNICEF for the supply of its paediatric vaccines, an order likely to relieve some market fears about the product's growth potential. Report

> The FDA announced approval Thursday of Natazia, Bayer's combination hormonal tablet, for use as an oral contraceptive. Report

Biotech News

 @FierceBiotech: Burrill: Focus on patients, not molecules. Report | Follow @FierceBiotech 

 @JohnCFierce: Whatever else you might say about Cytori, it won't make any believers at the FDA with a small stem cell trial like this. Report | Follow @JohnCFierce

ImmunoGen collects $67M from public offering. Report

> Sarcoma Foundation calls for radical change in FDA review process. Article

> Cytori touts signs of efficacy in small stem cell trial. Article

> New biotech incubator opens at Berkeley. Story

And Finally... Scientists found evidence that drugs being developed for some cancers may also help fight age-related diseases like dementia and Alzheimer's. Report

Suggested Articles

WuXi AppTec has appointed Celgene CAR-T program veteran David Chang to lead its cell and gene therapy CDMO, WuXi Advanced Therapies.

Maryland-based Emergent BioSolutions has won a $628 million contract with BARDA to manufacture targeted COVID-19 vaccine hopefuls.

About 76% remdesivir patients had at least one point of clinical improvement on a 7-point scale at day 11, versus 66% of patients on standard care.